Fractional exhaled nitric oxide nonsuppression identifies corticosteroid-resistant type 2 signaling in severe asthma.
Abstract
No abstract available
Citations
Altmetric:
Date
2021-09-15
Type
Article
Subject
Respiratory medicine
Collections
Citation
Couillard S, Shrimanker R, Chaudhuri R, Mansur AH, McGarvey LP, Heaney LG, Fowler SJ, Bradding P, Pavord ID, Hinks TSC. Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma. Am J Respir Crit Care Med. 2021 Sep 15;204(6):731-734. doi: 10.1164/rccm.202104-1040LEa
Journal / Source Title
American Journal of Respiratory and Critical Care Medicine
DOI
10.1164/rccm.202104-1040LE
PMID
34129808
Publisher
American Thoracic Society
Publisher’s URL
https://www.atsjournals.org/journal/ajrccm